Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients

计划入组 95 人 · 首次发布于 2023 年 3 月 15 日

Treatment of BK Virus Infection With CTL Cells in Immunocompromised Transplant Patients

计划入组 20 人 · 首次发布于 2020 年 3 月 3 日

Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy

计划入组 108 人 · 首次发布于 2005 年 9 月 12 日

Anti-BK polyomavirus

BK polyomavirus(Orthogon Therapeutics)

BK polyomavirus program (oral, BK virus infection)

Associated Capital

United States

Associated Medical Supplies Ltd

Canada

HAMILTON CDN BK MEAN RVSON IDX ETF UNIT

United States

Ipsen to Acquire Memo Therapeutics in Deal Worth Over €700 Million, Securing Phase II BK Polyomavirus Antibody Potravitug

Memo Therapeutics AG Completes Enrollment in Phase II Trial of Potravitug for BK Viremia

Memo Therapeutics AG Completes Enrollment in Phase II Trial of Potravitug for BK Viremia